Today's Top Stories | | By Thomas Hughes | June 23, 2026 07:15 AM |
| | | By Jeffrey Neal Johnson | June 23, 2026 06:40 AM |
| | By Chris Markoch | June 22, 2026 12:45 PM |
| | | By Peter Frank | June 22, 2026 10:55 AM |
| | By Ryan Hasson | June 22, 2026 10:20 AM |
|
|
Analysts' Upgrades | | Demant A/S (OTCMKTS:WILYY) was upgraded by Morgan Stanley from "equal weight" to "overweight". The current price is $19.25. | | International Business Machines (NYSE:IBM) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $291.00 price target on the stock, up from $270.00. This represents a 11.4% upside from the current price of $261.32. | | Kone Oyj (OTCMKTS:KNYJY) was upgraded by Kepler Capital Markets from "hold" to "buy". The current price is $28.13. | | Sonova (OTCMKTS:SONVY) was upgraded by Morgan Stanley from "underweight" to "equal weight". The current price is $47.90. |
|
View More Upgrades
|
Analysts' Downgrades | | Darden Restaurants (NYSE:DRI) was downgraded by Evercore Inc from "outperform" to "in-line". They now have a $230.00 price target on the stock. This represents a 8.6% upside from the current price of $211.85. | | Hermes International (OTCMKTS:HESAY) was downgraded by HSBC Holdings plc from "buy" to "hold". The current price is $185.20. | | Inspire Medical Systems (NYSE:INSP) was downgraded by Evercore Inc from "outperform" to "in-line". They now have a $40.00 price target on the stock. This represents a 2.2% downside from the current price of $40.89. | | Ross Stores (NASDAQ:ROST) was downgraded by Wells Fargo & Company from "overweight" to "equal weight". They now have a $245.00 price target on the stock. This represents a 4.8% upside from the current price of $233.76. | | Telenor ASA (OTCMKTS:TELNY) was downgraded by Barclays PLC from "equal weight" to "underweight". The current price is $14.90. |
|
View More Downgrades
|
 | Do this before Elon’s next tweet (Ad)Jeff Brown picked Nvidia in 2016 - up 25,155% since. He recommended Bitcoin at $240 - up 31,219% since. Now he says Elon Musk is about to make his latest invention available to the public, and one critical partner stock could surge when he does.
Brown expects the announcement any day - possibly posted on X before month's end. He's identified the company Elon can't operate without, and he wants you to see the name before it's front-page news.
Click here to see the name of Elon's critical partner stock now |
|
Analysts' New Coverage | | Centene (NYSE:CNC) is now covered by Royal Bank Of Canada. They set a "sector perform" rating and a $70.00 price target on the stock. This represents a 9.6% upside from the current price of $63.89. | | DexCom (NASDAQ:DXCM) is now covered by Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $86.00 price target on the stock. This represents a 23.2% upside from the current price of $69.79. | | Factorial Energy (NASDAQ:FAC) is now covered by Cantor Fitzgerald. They set an "overweight" rating and a $18.00 price target on the stock. This represents a 31.7% upside from the current price of $13.67. | | Insulet (NASDAQ:PODD) is now covered by Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $190.00 price target on the stock. This represents a 30.9% upside from the current price of $145.10. | | Louisiana-Pacific (NYSE:LPX) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $93.00 price target on the stock. This represents a 23.0% upside from the current price of $75.64. | | Nkarta (NASDAQ:NKTX) is now covered by TD Cowen. They set a "buy" rating on the stock. The current price is $2.92. | | Smurfit Westrock (NYSE:SW) is now covered by Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $57.00 price target on the stock. This represents a 27.0% upside from the current price of $44.90. | | Tandem Diabetes Care (NASDAQ:TNDM) is now covered by Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $15.50 price target on the stock. This represents a 9.3% upside from the current price of $14.18. |
|
View More New Coverage
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
|
